Dashboard PDUFA PDUFA History Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free public preview Track LLY with free AI briefings, catalyst countdowns, and dilution alerts.

LLY

FDA catalysts, PDUFA dates with approval probability, drug pipeline, cash runway and insider activity — updated automatically from SEC, FDA and ClinicalTrials.gov data.

$9B Cash on Hand

CF+ Cash Runway

1% Short Interest

🧪 Upcoming Trial Catalysts

2026-10-01 · Phase 3 — Active Trial — A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old W
2026-12-01 · Phase 1 — Recruiting — A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
2027-01-01 · Phase 1 — Upcoming Trial — A Study of LY4355756 in Healthy Participants
2027-05-01 · Phase 2 — Recruiting — A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children a
2027-06-01 · Phase 1 — Upcoming Trial — A Study of Macupatide (LY3532226) in Participants With Obesity or Overweight Without Type
2027-07-01 · Phase 1 — Recruiting — A Study of LY4088044 in Healthy Participants

📊 Drug Pipeline

Drug	Indication	Phase	Status
anti-integrin antibodies	Ulcerative Colitis (UC)	PHASE4	ENROLLING_BY_INVITATION
Anti-TNF agents	Ulcerative Colitis (UC)	PHASE4	ENROLLING_BY_INVITATION
Diphenoxylate/Atropine	Pouch, Ileal	PHASE4	NOT_YET_RECRUITING
Idelalisib	Chronic Lymphocytic Leukemia	PHASE4	RECRUITING
IL-12	Ulcerative Colitis (UC)	PHASE4	ENROLLING_BY_INVITATION
IL-23	Ulcerative Colitis (UC)	PHASE4	ENROLLING_BY_INVITATION
Loperamide	Pouch, Ileal	PHASE4	NOT_YET_RECRUITING
Mirikizumab	Ulcerative Colitis (UC)	PHASE4	ENROLLING_BY_INVITATION
Tirzepatide	Pouch, Ileal	PHASE4	NOT_YET_RECRUITING
Abemaciclib	Breast Neoplasms	PHASE3	RECRUITING

💰 Cash Runway & Dilution Risk

LLY holds $9B in cash and its operations are currently cash-flow neutral or positive. A recent offering filing was detected — dilution watch.

Source: SEC EDGAR XBRL (operating cash flow). Get dilution alerts for LLY free →

📈 Recent Insider Activity (Form 4)

Date	Insider	Type	Value
2026-08-11	Zakrowski Donald A	Sale	$1.8M
2026-08-10	Hakim Anat	Sale	$14.1M
2026-08-03	Seymour Melissa	Purchase	$0
2026-08-03	Seymour Melissa	Sale	$1.2M
2026-08-03	Seymour Melissa	Sale	$0

Get the full LLY picture

A free BioRadar account adds AI daily briefings, sentiment tracking, trial enrollment progress, and email alerts for LLY and 2 more tickers of your choice.

Create Free Account →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z